<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Empiric antimicrobial regimens for febrile young infants younger than 90 days of age without focal infections*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Empiric antimicrobial regimens for febrile young infants younger than 90 days of age without focal infections*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Empiric antimicrobial regimens for febrile young infants younger than 90 days of age without focal infections*</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup span="2" width="40%"></colgroup> <tbody> <tr> <td class="subtitle1">Age</td> <td class="subtitle1">Common pathogens</td> <td class="subtitle1">Empiric treatment</td> </tr> <tr> <td>Neonate (≤28 days)</td> <td> <p>Common: Group B <em>Streptococcus</em>, <em>E. coli</em></p> Less common: <em>Listeria monocytogenes</em>, <em>Enterococcus</em>, <em>S. aureus</em>, other Gram negative organisms, HSV</td> <td> <ul> <li>Ampicillin<br/> <strong>and</strong><br/> ceftazidime <strong>or</strong> cefepime <strong>or</strong> cefotaxime (if available) <strong>or</strong> gentamicin<sup>¶</sup></li> <li>Add acyclovir when indicated<sup>Δ</sup></li> <li>Add vancomycin when indicated<sup>◊</sup></li> </ul> </td> </tr> <tr> <td>Infant (29 to 60 days)</td> <td> <p>Common: Group B <em>Streptococcus</em>, <em>E. coli</em>, <em>S. pneumoniae</em>, <em>H. influenzae</em>, <em>N. meningitidis</em>, <em>S. aureus</em></p> Less common: <em>Enterococcus</em>, <em>Listeria monocytogenes</em>, Pseudomonas sp., other Gram negative organisms</td> <td> <ul> <li>Ceftriaxone <strong>or</strong> cefotaxime (if available)</li> <li>Add ampicillin, when coverage for <em>Enterococcus</em> or <em>Listeria monocytogenes</em> infection is indicated or when meningitis is suspected</li> <li>Add vancomycin, when indicated<sup>◊</sup></li> <li>Add gentamicin, when broader coverage for Gram negative pathogens is indicated</li> <li>Add acyclovir when indicated<sup>Δ</sup></li> </ul> </td> </tr> <tr> <td>Infant (61 to 90 days)</td> <td> <p>Common: <em>S. pneumoniae</em>, <em>H. influenzae</em>, <em>N. meningitidis</em></p> Less common: Group B <em>Streptococcus</em>, <em>E. coli</em>, <em>S. aureus</em>, <em>Enterococcus</em>, <em>Listeria monocytogenes</em>, Pseudomonas sp., other Gram negative organisms</td> <td> <ul> <li>Ceftriaxone <strong>or</strong> cefotaxime (if available)</li> <li>Add vancomycin when indicated<sup>◊</sup></li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>HSV: herpes simplex virus.</p>
<p>* Broad-spectrum coverage is prudent until an organism is identified. For specific drug dosing, refer to Lexicomp drug monographs available by searching UpToDate, or while in an UpToDate topic, clicking on the drug name. Refer to UpToDate topics on management of febrile infants younger than 90 days of age.</p>
<p>¶ The choice of regimen should be based on local susceptibility patterns of <em>E. coli</em> and likelihood of <em>L. monocytogenes</em> infection or <em>Enterococcus</em> infection. Per the American Academy of Pediatrics Clinical Practice <a href="https://publications.aap.org/pediatrics/article/148/2/e2021052228/179783/Evaluation-and-Management-of-Well-Appearing" target="_blank">Guidelines</a>, selected well-appearing neonates 22 to 28 days old with normal inflammatory markers may be eligible for intramuscular ceftriaxone and discharge home to reliable caregivers as long as a follow-up visit within 12 to 24 hours for physical examination, review of culture results, and a repeated dose of ceftriaxone is assured.</p>
<p>Δ Acyclovir is indicated in asymptomatic infants ≤28 days but at risk due to exposure (maternal active genital lesions); those with ill appearance, mucocutaneous vesicles, seizures, or cerebrospinal fluid pleocytosis; and in older infants with clinical findings of HSV infection.</p>
<span class="lozenge">◊</span> Vancomycin is warranted for coverage of methicillin-resistant <em>S. aureus</em> infection in regions with high prevalence (&gt;10% of isolates) and for coverage of resistant <em>S. pneumoniae</em> in infants older than 28 days of age who are ill appearing or have findings of bacterial meningitis.</div><div id="graphicVersion">Graphic 55679 Version 11.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
